UNLABELLED: We present results of a randomized, placebo-controlled trial to examine the effect of 50 mg daily oral DHEA supplementation for one year on bone mineral density (BMD), bone metabolism and body composition in 225 healthy adults aged 55 to 85 years. INTRODUCTION:Dehydroepiandrosterone (DHEA) levels decline dramatically with age, concurrent with the onset of osteoporosis, suggesting a role for DHEA supplementation in preventing age-related bone loss. METHODS: We conducted a randomized, placebo-controlled trial to examine the effect of 50 mg daily oral DHEA supplementation for one year on bone mineral density (BMD), bone metabolism and body composition in 225 healthy adults aged 55 to 85 years. RESULTS:DHEA treatment increased serum DHEA and DHEA sulfate levels to concentrations seen in young adults. Testosterone, estradiol and insulin-like growth factor (IGF-1) levels increased in women (all p < 0.001), but not men, receiving DHEA. Serum C-terminal telopeptide of type-1 collagen levels decreased in women (p = 0.03), but not men, whereas bone-specific alkaline phosphatase levels were not significantly altered in either sex. After 12 months, there was a positive effect of DHEA on lumbar spine BMD in women (p = 0.03), but no effect was observed for hip, femoral neck or total body BMD, and no significant changes were observed at any site among men. Body composition was not affected by DHEA treatment in either sex. CONCLUSION: Among older healthy adults, daily administration of 50 mg of DHEA has a modest and selective beneficial effect on BMD and bone resorption in women, but provides no bone benefit for men.
RCT Entities:
UNLABELLED: We present results of a randomized, placebo-controlled trial to examine the effect of 50 mg daily oral DHEA supplementation for one year on bone mineral density (BMD), bone metabolism and body composition in 225 healthy adults aged 55 to 85 years. INTRODUCTION:Dehydroepiandrosterone (DHEA) levels decline dramatically with age, concurrent with the onset of osteoporosis, suggesting a role for DHEA supplementation in preventing age-related bone loss. METHODS: We conducted a randomized, placebo-controlled trial to examine the effect of 50 mg daily oral DHEA supplementation for one year on bone mineral density (BMD), bone metabolism and body composition in 225 healthy adults aged 55 to 85 years. RESULTS:DHEA treatment increased serum DHEA and DHEA sulfate levels to concentrations seen in young adults. Testosterone, estradiol and insulin-like growth factor (IGF-1) levels increased in women (all p < 0.001), but not men, receiving DHEA. Serum C-terminal telopeptide of type-1 collagen levels decreased in women (p = 0.03), but not men, whereas bone-specific alkaline phosphatase levels were not significantly altered in either sex. After 12 months, there was a positive effect of DHEA on lumbar spine BMD in women (p = 0.03), but no effect was observed for hip, femoral neck or total body BMD, and no significant changes were observed at any site among men. Body composition was not affected by DHEA treatment in either sex. CONCLUSION: Among older healthy adults, daily administration of 50 mg of DHEA has a modest and selective beneficial effect on BMD and bone resorption in women, but provides no bone benefit for men.
Authors: P J Hunt; E M Gurnell; F A Huppert; C Richards; A T Prevost; J A Wass; J Herbert; V K Chatterjee Journal: J Clin Endocrinol Metab Date: 2000-12 Impact factor: 5.958
Authors: Catherine M Jankowski; Wendolyn S Gozansky; Robert S Schwartz; Daniel J Dahl; John M Kittelson; Stephen M Scott; Rachael E Van Pelt; Wendy M Kohrt Journal: J Clin Endocrinol Metab Date: 2006-05-30 Impact factor: 5.958
Authors: R Libè; L Barbetta; C Dall'Asta; F Salvaggio; C Gala; P Beck-Peccoz; B Ambrosi Journal: J Endocrinol Invest Date: 2004-09 Impact factor: 4.256
Authors: Yi-Hsiang Hsu; Scott A Venners; Henry A Terwedow; Yan Feng; Tianhua Niu; Zhiping Li; Nan Laird; Joseph D Brain; Steve R Cummings; Mary L Bouxsein; Cliff J Rosen; Xiping Xu Journal: Am J Clin Nutr Date: 2006-01 Impact factor: 7.045
Authors: Catherine M Jankowski; Pamela Wolfe; Sarah J Schmiege; K Sreekumaran Nair; Sundeep Khosla; Michael Jensen; Denise von Muhlen; Gail A Laughlin; Donna Kritz-Silverstein; Jaclyn Bergstrom; Richele Bettencourt; Edward P Weiss; Dennis T Villareal; Wendy M Kohrt Journal: Clin Endocrinol (Oxf) Date: 2018-12-09 Impact factor: 3.478
Authors: Catherine M Jankowski; Wendolyn S Gozansky; John M Kittelson; Rachael E Van Pelt; Robert S Schwartz; Wendy M Kohrt Journal: J Clin Endocrinol Metab Date: 2008-09-23 Impact factor: 5.958
Authors: Edward P Weiss; Krupa Shah; Luigi Fontana; Charles P Lambert; John O Holloszy; Dennis T Villareal Journal: Am J Clin Nutr Date: 2009-03-25 Impact factor: 7.045
Authors: Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson Journal: Endocr Rev Date: 2014-09-09 Impact factor: 19.871